Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Silverarc Capital Management, Llc
Form 13F · Q2 2026

Silverarc Capital Management, Llc

CIK 1816307Filed 2026-08-1313F-HR View the filing on EDGAR ↗
$962M
Reported book value
73
Positions
12
Quarters on record
Top 50
Positions

Silverarc Capital Management, Llc — holdings

Top 50 positions of 73, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1ASND Ascendis Pharma A/S206,234—$55M5.7%
2CELC Celcuity Inc500,996+40.0%$52M5.4%
3COGT Cogent Biosciences Inc1.3M−2.5%$50M5.2%
4URGN Urogen Pharma Ltd1.3M−13.4%$48M5.0%
5IMNM Immunome Inc2.0M+9.0%$43M4.4%
6DNTH Dianthus Therapeutics Inc390,000−40.4%$38M4.0%
7RYTM Rhythm Pharmaceuticals Inc311,461+1.8%$35M3.6%
8ORKA Oruka Therapeutics Inc352,802+133.8%$34M3.5%
9GLUE Monte Rosa Therapeutics Inc1.1M−44.6%$27M2.8%
10SNDX Syndax Pharmaceuticals Inc1.2M+36.6%$27M2.8%
11ELVN Enliven Therapeutics Inc489,382—$25M2.6%
12IMVT Immunovant Inc619,096+49.5%$24M2.5%
13ERAS Erasca Inc1.3M−31.8%$23M2.4%
14SGMT Sagimet Biosciences Inc2.9M—$23M2.4%
15ABIVAX SA Abivax Sa169,593−43.9%$23M2.3%
16PRAX Praxis Precision Medicines I65,679−8.2%$22M2.3%
17KOD Kodiak Sciences Inc546,256−44.9%$21M2.2%
18DFTX Definium Therapeutics Inc400,000—$19M2.0%
19VCYT Veracyte Inc318,001+77.0%$19M1.9%
20GH Guardant Health Inc99,826+1.3%$15M1.6%
21CCCC C4 Therapeutics Inc3.0M+58.6%$14M1.5%
22ZBIO Zenas Biopharma Inc509,789−55.1%$13M1.3%
23TRVI Trevi Therapeutics Inc678,095+32.7%$13M1.3%
24HLXC Helix Acquisition Corp Iii1.2M−2.6%$13M1.3%
25ALXO Alx Oncology Hldgs Inc5.7M—$12M1.2%
26MANE Veradermics Inc95,000—$12M1.2%
27XENE Xenon Pharmaceuticals Inc186,821−5.5%$11M1.2%
28AVALYN PHARMACEUTICALS INC Avalyn Pharmaceuticals Inc330,487—$11M1.1%
29BIIB Biogen Inc48,101−5.6%$10M1.1%
30ACRS Aclaris Therapeutics Inc1.9M—$10M1.1%
31CERS Cerus Corp3.5M+9.3%$10M1.1%
32AVTX Avalo Therapeutics Inc500,402—$9M1.0%
33BNTC Benitec Biopharma Inc679,826−5.3%$9M0.9%
34PCVX Vaxcyte Inc145,000+0.0%$8M0.9%
35WGS Genedx Holdings Corp122,269—$8M0.9%
36SVRA Savara Inc1.4M−5.3%$8M0.9%
37OVID Ovid Therapeutics Inc3.1M+210.1%$8M0.9%
38ORIC Oric Pharmaceuticals Inc738,873−32.8%$8M0.8%
39CMPS Compass Pathways Plc503,382+67.8%$7M0.7%
40CGEN Compugen Ltd3.2M−4.0%$7M0.7%
41SLDB Solid Biosciences Inc668,450—$7M0.7%
42IBIO Ibio Inc3.5M+1457.7%$6M0.6%
43IRON Disc Medicine Inc82,800−57.8%$6M0.6%
44ALKS Alkermes Plc113,494−75.3%$6M0.6%
45SYRE Spyre Therapeutics Inc59,959−67.9%$5M0.6%
46ARTV Artiva Biotherapeutics Inc525,000—$5M0.5%
47CTNM Contineum Therapeutics Inc296,135−1.9%$5M0.5%
48UNIQURE NV Uniqure Nv105,000—$5M0.5%
49RACC Research Alliance Corp Iii360,000—$4M0.4%
50ABEO Abeona Therapeutics Inc610,407−5.9%$4M0.4%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.